September 21, 2007 - Hologic Inc., a provider of diagnostic imaging and state-of-the-art digital imaging systems directed towards women’s health, recently announced the acquisition of BioLucent Inc., a market leader in its development and sale of its MammoPad breast cushion.
BioLucent, located in Aliso Viejo, California, develops, markets and sells a breast cushion, MammoPad, to decrease the discomfort associated with mammography. BioLucent’s primary research and development efforts are directed at its brachytherapy business which is focused on breast cancer therapy.
Prior to the acquisition, BioLucent completed the spin-off its brachytherapy technology and business to the holders of BioLucent’s outstanding shares of capital stock. The new company, Cianna Medical will manufacture and market the SAVI applicator. As a result Hologic acquired BioLucent’s Mammopad business and related assets.
The aggregate purchase price paid by Hologic to the security holders of BioLucent at the closing of the acquisition, exclusive of certain transaction costs and expenses, was approximately $70.0 million, of which amount $65.0 million was paid by Hologic in shares of Hologic’s common stock valued at $54.222 per share and $5.0 million was paid in cash.
For more information: www.hologic.com.